PR Newswire Clinical TrialsOriginal article
Monteris Medical Announces Publication of Landmark Study on 787 Brain Tumor Patients Treated with NeuroBlate® Laser Interstitial Thermal Therapy (LITT)
Data ReadoutpositiveNeuroBlate®Positive
AI Analysis
Summary
Monteris Medical announced publication of landmark LAANTERN Study data on 787 brain tumor patients treated with NeuroBlate laser therapy, identifying ablation extent and lesion size as key survival determinants. The positive findings reinforce Monteris' leadership in minimally invasive neuro-oncology.
Clinical Trial Data
Primary Endpoint
Met
Patients
787
Outcome Details
LAANTERN Study on 787 brain tumor patients identifies extent of ablation and lesion size as key determinants of survival
Importance:6/10
Sentiment:
0.70
neuro-oncologyminimally invasivelaser interstitial thermal therapyLITTclinical datastudy publication
Read the original article
Published by PR Newswire Clinical Trials on August 19, 2026 1:30 PM